MARLBOROUGH, Mass., May 22, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX™ left atrial appendage closure (LAAC) platform to first-line oral anticoagulants (OAC) – including direct oral anticoagulants (DOAC) and warfarin – for stroke risk reduction in patients with […]
Other News
Sotera Wireless Welcomes New Chief Operating Officer
SAN DIEGO–(BUSINESS WIRE)–Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announced today the appointment of veteran engineering and operations executive Younes Achkire, PhD, as its new Chief Operating Officer. With a doctorate from the Free University of Brussels and post-doctorate […]
ClearFlow Names Michael Elniski VP of Global Sales
ANAHEIM, Calif,–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales. Elniski, who most recently served as Franchise VP of Cardiac Critical Care at Merit Medical and was previously VP of Healthcare Solutions at Edwards Lifesciences, is recognized […]
Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients
DUBLIN and PARIS – May 22, 2019 – Investigators today unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial. The data indicate that renal denervation (RDN) with the Medtronic Symplicity(TM) renal denervation system was associated with reduced occurrence of subclinical atrial fibrillation (AF) in a small subset of high-risk […]
Edwards Announces Milestones For Transcatheter Mitral Program
PARIS, May 22, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of […]
Pi-Cardia First-in-Human Study Shows Significant Improvement in Aortic Valve Function Following Treatment With its Novel Non-Implant Based Leaflex™ Catheter
PARIS, May 22, 2019 /PRNewswire/ — Pi-Cardia Ltd. announced today that it successfully completed its First-in-Human study demonstrating substantial improvement in valve function following treatment with its Leaflex™ Performer catheter. The Leaflex™ Performer is a transfemoral catheter that uses two unique mechanical structures for scoring valve calcification at multiple locations, restoring leaflets […]
WomenHeart Celebrates 20 Years of Service and Honors Women’s Heart Health Advocates at Annual Wenger Awards
WASHINGTON–(BUSINESS WIRE)–WomenHeart: The National Coalition for Women with Heart Disease recognized contributions to women’s cardiovascular health at its 2019 Wenger Awards. The organization also celebrated 20 years of providing support, education and advocacy for the 48 million women living with or at risk of heart disease. “It’s been an incredible […]
Hemovent Receives CE Marking for MOBYBOX™ ECLS System
AACHEN, Germany–(BUSINESS WIRE)–Hemovent GmbH announced today that it has received CE Marking for its MOBYBOX™ ECLS System, allowing the company to market its innovative product throughout the European Union. MOBYBOX is a miniaturized heart/lung machine that uses Hemovent’s proprietary Bionique Flow Technologies as its platform. As the world’s first self-contained and fully integrated […]
First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy
ZURICH–(BUSINESS WIRE)–Regulatory News: Vifor Pharma today announced that treatment of the first patient in their global phase-IIIb DIAMOND study has begun. The study will evaluate the potential of Veltassa® to improve outcomes by enabling heart failure (HF) patients, with or without chronic kidney disease (CKD), to be treated with renin-angiotensin-aldosterone system […]
DABRA Laser to be Presented as a Frontline Therapy for CLI at the 2019 SCAI Scientific Sessions
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED) today announced that Dr. Mohammad Ansari will present DABRA as a treatment for critical limb ischemia (CLI) during a scientific case review May 21 at the SCAI annual meeting in Las Vegas. “The unique DABRA catheter and laser system is a highly effective frontline […]



